Chudova Darya 4
4 · Guardant Health, Inc. · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
Guardant Health (GH) CTO Darya Chudova Converts RSUs; Shares Withheld
What Happened Darya Chudova, Chief Technology Officer of Guardant Health, converted a series of restricted stock units (RSUs) on July 1, 2026, resulting in 8,030 shares being issued. The company withheld 4,318 of those shares to satisfy tax withholding obligations, valued at $170.77 per share for a total tax withholding of $737,385. After withholding, Chudova received a net 3,712 shares.
Key Details
- Transaction date: July 1, 2026; Form 4 filed July 2, 2026 (timely).
- Conversion entries coded "M" (exercise/conversion of derivative) for 1,339; 1,667; 3,324; and 1,700 shares (total 8,030 shares).
- Withholding entry coded "F": 4,318 shares withheld at $170.77/share = $737,385 to cover taxes.
- Net shares received: 3,712 (8,030 issued − 4,318 withheld).
- Footnotes: withholding was to meet tax liability and was not in excess of the tax due (F1). The converted shares relate to RSU grants from 11/7/2022, 12/13/2023, 11/8/2024 and 3/12/2025 with staggered vesting schedules (F2, F4, F5, F6). F3 not applicable.
- Additional note in the filing: Table I includes 259 shares acquired under Guardant Health's ESPP on 5/14/2026.
- Filing timing: reported within one business day of the transactions (not late).
Context This was a routine RSU vesting/conversion with a portion of shares withheld to satisfy tax obligations (a common practice), not an open-market sale or purchase. The "M" entries reflect conversion/settlement of derivative awards (RSUs); the "F" entry records tax-withholding via share retention. Such vesting and withholding are administrative and do not by themselves indicate insider buying or selling intent.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-07-01+1,339→ 76,000 total - Exercise/Conversion
Common Stock
2026-07-01+1,667→ 77,667 total - Exercise/Conversion
Common Stock
2026-07-01+3,324→ 80,991 total - Exercise/Conversion
Common Stock
2026-07-01+1,700→ 82,691 total - Tax Payment
Common Stock
[F1]2026-07-01$170.77/sh−4,318$737,385→ 78,373 total - Exercise/Conversion
Restricted Stock Units
[F2][F3]2026-07-01−1,339→ 1,340 totalExercise: $0.00→ Common Stock (1,339 underlying) - Exercise/Conversion
Restricted Stock Units
[F4][F3]2026-07-01−1,667→ 1,668 totalExercise: $0.00→ Common Stock (1,667 underlying) - Exercise/Conversion
Restricted Stock Units
[F5][F3]2026-07-01−3,324→ 16,620 totalExercise: $0.00→ Common Stock (3,324 underlying) - Exercise/Conversion
Restricted Stock Units
[F6][F3]2026-07-01−1,700→ 11,903 totalExercise: $0.00→ Common Stock (1,700 underlying)
Footnotes (6)
- [F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- [F2]This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
- [F3]Not applicable for Restricted Stock Units.
- [F4]This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- [F5]This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- [F6]This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.